Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Journal of Clinical Oncology (JCO) Podcast - Novel Insights From a Phase II MEK Inhibitor Trial in BRAF Mutant Melanoma

Novel Insights From a Phase II MEK Inhibitor Trial in BRAF Mutant Melanoma

Journal of Clinical Oncology (JCO) Podcast

12/19/12 • 7 min

plus icon
bookmark
Share icon
A discussion of a phase 2 trial of a MEK inhibitor in patients with V600 BRAF mutations and consideration of other relevant results with targeted therapies in this population.

12/19/12 • 7 min

plus icon
bookmark
Share icon

Episode Comments

0.0

out of 5

Star filled grey IconStar filled grey IconStar filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey Icon
Star filled grey Icon

No ratings yet

Star iconStar iconStar iconStar iconStar icon

Join the conversation

Post

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/journal-of-clinical-oncology-jco-podcast-448/novel-insights-from-a-phase-ii-mek-inhibitor-trial-in-braf-mutant-mela-65956"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to novel insights from a phase ii mek inhibitor trial in braf mutant melanoma on goodpods" style="width: 225px" /> </a>

Copy